Michelle F Devine
University of Rochester
Sleep in non-human animalsInternal medicineNothingEtiologyHyperintensityAntibodyNeurologyRandomized controlled trialAdverse effectPlacebo-controlled studyBiopsyTesticular cancerImmunotherapyEpilepsyLymph node biopsyTrismusMalignancyHypoventilationAutoimmunityCurseHearing lossMultiple sclerosisImmune checkpointAtaxiaTesticular microlithiasisAutoimmune encephalitisSleep-related respiratory failureNeurological syndromeOnconeural antibodiesSeizure frequencyDiagnostic informationImmune checkpoint inhibitorsDiagnostic evaluationBioinformaticsMedicineEncephalitisGastroenterology
6Publications
3H-index
72Citations
Publications 8
Newest
#1Michelle F Devine (UR: University of Rochester)H-Index: 3
#3Divyanshu Dubey (Mayo Clinic)H-Index: 22
Source
#1Michelle F Devine (UR: University of Rochester)H-Index: 3
#2Naga Kothapalli (University of Pittsburgh)
Last. Divyanshu Dubey (Mayo Clinic)H-Index: 22
view all 4 authors...
We provide an overview of the varied presentations of paraneoplastic neurological syndromes. We also review the onconeural antibodies and their particular oncological and neurological associations....
Source
#1Michelle F DevineH-Index: 3
#1Michelle F. DevineH-Index: 3
Last. Erik K. St. LouisH-Index: 30
view all 2 authors...
Associations between sleep disorders and neurological autoimmunity have been notably expanding recently. Potential immune-mediated etiopathogenesis has been proposed for various sleep disorders including narcolepsy, Kleine-Levin syndrome, and Morvan syndrome. Sleep manifestations are also common in various autoimmune neurological syndromes, but may be underestimated as overriding presenting (and potentially dangerous) neurological symptoms often require more urgent attention. Even so, sleep dysf...
1 CitationsSource
#1Divyanshu DubeyH-Index: 22
#2Michael R. Wilson (UCSF: University of California, San Francisco)H-Index: 35
Last. Sean J. Pittock (Mayo Clinic)H-Index: 79
view all 33 authors...
Importance Recognizing the presenting and immunopathological features of Kelch-like protein-11 immunoglobulin G seropositive (KLHL11 IgG+) patients may aid in early diagnosis and management. Objective To describe expanding neurologic phenotype, cancer associations, outcomes, and immunopathologic features of KLHL11 encephalitis. Design, Setting, and Participants This retrospective tertiary care center study, conducted from October 15, 1998, to November 1, 2019, prospectively identified 31 KLHL11 ...
12 CitationsSource
#1Michelle F Devine (Mayo Clinic)H-Index: 3
#1M.F. Devine (Mayo Clinic)H-Index: 1
Last. E. St. Louis (Mayo Clinic)H-Index: 3
view all 10 authors...
1 CitationsSource
#1Divyanshu DubeyH-Index: 22
#2Michael R. Wilson (University of California, Berkeley)H-Index: 35
Last. Sean J. Pittock (Mayo Clinic)H-Index: 79
view all 30 authors...
Objective: To describe phenotypic presentations, outcomes and histopathological features and T cell responses in Kelch-like protein 11 (KLHL11) encephalitis. Background: KLHL11-IgG is a newly identified biomarker of paraneoplastic encephalitis. Design/Methods: Clinical features and outcomes of KLHL11-IgG seropositive cases identified in the Mayo Clinic Neuroimmunology Laboratory (confirmed by transfected-cell and tissue-based immunofluorescence assays) were reviewed. Peripheral blood mononuclear...
#1Divyanshu Dubey (Mayo Clinic)H-Index: 22
#2Jeffrey W. Britton (Mayo Clinic)H-Index: 37
Last. Sean J. Pittock (Mayo Clinic)H-Index: 79
view all 14 authors...
Objective Drug‐resistant seizures are common in patients with leucine‐rich, glioma‐inactivated 1 (LGI1)‐IgG associated and contactin‐associated protein‐like 2 (CASPR2)‐IgG associated encephalitis. We performed the first randomized double‐blind placebo‐controlled trial to evaluate efficacy of intravenous immunoglobulin (IVIG) in reducing seizure frequency.
30 CitationsSource
#1Michelle F DevineH-Index: 3
#1M.F. DevineH-Index: 1
Last. E. St. LouisH-Index: 3
view all 9 authors...
1 CitationsSource